{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/reducing-white-space-early-stage-drug-development-strategies-streamlined-success#webpage",
"url": "https://www.fortrea.com/insights/reducing-white-space-early-stage-drug-development-strategies-streamlined-success",
"name": "Strategic Roadmap for Drug Development: Enhancing Efficiency and Reducing Costs While Increasing the Probability of Success",
"description": "Explore this Fortrea white paper on strategic roadmap approaches for drug development and discover how integrated development planning is helping organizations strengthen clinical development strategy, improve development decision-making, and optimize execution across the full product lifecycle. The white paper examines key considerations involved in building a strategic roadmap for drug development, including integrated drug development planning, clinical development roadmaps, lifecycle coordination, regulatory alignment, milestone-based planning, and evidence-based development strategies designed to improve efficiency and streamline execution. Learn how coordinated development planning, adaptive clinical development approaches, strategic portfolio management, regulatory and clinical alignment, cross-functional collaboration, and end-to-end development frameworks are helping organizations reduce inefficiencies, improve development continuity, strengthen decision-making, and support more effective drug development programs from early planning through long-term lifecycle management."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Strategic Roadmap for Drug Development: Enhancing Efficiency and Reducing Costs While Increasing the Probability of Success",
"item": "https://www.fortrea.com/insights/reducing-white-space-early-stage-drug-development-strategies-streamlined-success"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/recognizing-new-normal-patient-centric-clinical-studies#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/recognizing-new-normal-patient-centric-clinical-studies#webpage"
},
"headline": "Strategic Roadmap for Drug Development & Integrated Development Planning | Fortrea White Paper",
"description": "Explore this Fortrea white paper on strategic roadmap approaches for drug development and discover how integrated development planning is helping organizations strengthen clinical development strategy, improve development decision-making, and optimize execution across the full product lifecycle. The white paper examines key considerations involved in building a strategic roadmap for drug development, including integrated drug development planning, clinical development roadmaps, lifecycle coordination, regulatory alignment, milestone-based planning, and evidence-based development strategies designed to improve efficiency and streamline execution. Learn how coordinated development planning, adaptive clinical development approaches, strategic portfolio management, regulatory and clinical alignment, cross-functional collaboration, and end-to-end development frameworks are helping organizations reduce inefficiencies, improve development continuity, strengthen decision-making, and support more effective drug development programs from early planning through long-term lifecycle management.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-09-04",
"dateModified": "2025-09-04",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-11/strategic-roadmap-for-drug-development_0.pdf",
"encodingFormat": "application/pdf"
}
}
]
}